Relation of Antipsoriatic and Langerhans Cell Depleting Effects of Systemic Psoralen Photochemotherapy: A Clinical, Enzyme Histochemical, and Electron Microscopic Study  by Koulu, Leena et al.
002 2- 202X/84 /8206-059 1 $02.00/0 
TH E JOUllNAL OF I NVESTIGATIVE DEilMATOLOGY, 82:591- 593, 1984 
Copyri ghi @ 1984 by The Williams & Wilkins Co. 
Vol. 82, No. 6 
Printed in U.S.A. 
Relation of Antipsoriatic and Langerhans Cell Depleting Effects of 
Systemic Psoralen Photochemotherapy: A Clinical, Enzyme 
Histochemical, and Electron Microscopic Study 
LEENA KOULU, M.D., KARL-0VE SODERSTROM, M.D., AND CHRISTER T. JANSEN , M.D. 
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The possible relation between the therapeutic action 
and Langerhans cell (LC) depleting effect of psoralen 
photochemotherapy (PUV A) was _investigate~ i~ 9 pso-
riatic patients by parallel recordmg of the chmcai sta-
tus using the psoriasis area and severity index (PAS I), 
and the epidermal LC counts of uninvolved skin, using 
light (ATPase staining) an~ electro? microscopy (EM). 
Both light and electron miCroscopiCally recorded LC 
numbers decreased significantly during the PUV A 
course of on the average, 21 exposures and a mean cumulati~e UVA dose of 77 J/cm2 • At the end of_the 
treatment period, both the P ASI score and the hght 
microscopically recorded LC density had reduced to 
about one-tenth of original, i.e., from 7.5::!: 5 .7 to 0.8::!: 
o.B points and from 787 ::!: 70 to 60 ::!: 48 cells/mm2 , 
respectively. After cessation of the PUV A course, the 
pASI scores remained low during the 3-7-week follow-
up period, while the LC counts returned to normal, and 
even exceeded the starting value by _12%. Although a 
possible functional impairment of LC m the post-PUVA 
period cannot be excluded, the ?ata are interpreted ~s 
peaking against the hypothesis that the therapeutic ~ction of PUV A would be mediated through its LC ef-
fects. 
For about a decade , PUV A has been used with great success 
· the treatment of psoriasis [1], but the exact mode of action ~ th is therapy is sti ll a matter of_unce~taint~. While a direct 
hototoxic effect on the hyperprohferative epidermal cells has 
been postulated [2), indirect effects could als? be mvolved. One 
intriguing possibili ty is that the therapeutic effect cou ld be 
mediated t hrough a n action of photoc_hemot herapy_ ?n the 
epidermal LC. These cells ~ave b~en imphcate_d as partiCipatm~ 
in t he regulation of keratimzatwn [3] and m modulatiOn of 
imm unologic phenomena in the s kin [ 4]; b?th a~pects have 
importa n t bearings on the pathophysiology of ps~nasis. ~ore­
over in psoriatic p laques bot h t he number and distnbutwn of 
LC have been s hown to be abnormal [5-7]. Recent findings 
':hat PUV A can affect t he number, general morphology, and 
;urface markers of huma n LC a re most exciting [8- ~4]. While 
t hese findings lend indirect support to the hypothes i ~ t hat LC 
could play a key role in the mediation of the a ntipso n atic 
effects of photochemotherapy, direct proof for t his theory is 
lacking. We now report a study where the role of ~C in the. 
PUV A hea lin g process was a na lyzed by parall e l momtonng of 
t he clinical effect of photochemotherapy and t he number and 
ult rastructura l morphology of ATPase-pos itive epidermal LC 
of psoriatic patie nts. 
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Abbreviations: 
EM: electron microscopy 
LC: Langerhans cell(s) 
PASI: psorias is area and severi ty index 
PUV A: psora len photochemotherapy 
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MATERIALS AND METHODS 
Patients 
Nine male patients suffering from pso rias is vu lgaris of moderate 
extent and scheduled to start systemic P UVA therapy at t he Depart-
ment of Dermatology, University Hospital of Turku, were included in 
t he study, after obta ining t heir informed consent. The ages of the 
patients varied from 20- 68 years, mean 44 years. 
Ph.ot.ochemotherapy 
The patients were irradiated 2-3 times a week, 2 h after having 
taken app roximately 0.6 mg/ kg of8-methoxypsoralen ora lly (Puvaderm 
tablets, Star Ltd, Tampere, Finland). For irradiation, stand-up cabinets 
equ ipped with fluorescent tubes emitting in t he 315-410 nm region 
with a maxim um at 360 nm were used (PUVA 22, Airam Ltd, Helsinki, 
Finland) . Sta rtin g UVA dose was 1.5 J /cm2 , with gradual increase to a 
maximum dose of 2.5- 9 J jcm2• During the entire period of t he study, 
no other treatments were allowed to the patients except the use of 
emollient creams. 
Clinical Scoring 
Before start ing t he PUVA therapy, and at every 5th- 10th treatment, 
the clinical status of t he patient was evaluated, using the PASI as 
described by Fredriksson and Pettersson 115]. excluding, however, t he 
readings for the head region. Additional readings were made 2 weeks 
and 3-7 weeks afte r cessation of the t herapy. 
ATPase Staining 
For light microscopic observations of LC, punch biopsies from the 
lateral side of the upper arm (uninvolved skin) were obtained at each 
examination . Epidermal sheets were separated from the biopsy speci-
mens by EDTA t reatment, and t he LC stained by ATPase as described 
by Juhlin and Shelley [1 6]. The cell numbers were counted from 20 
fields after projection of the stained epidermal specimen on a Reichert 
microscope projector screen at a magnification of 200x. 
Electron Microscopy 
In 4 of the patients, a part of the EDT A-separated epidermal sample 
was processed for EM by fix ation in 3% glutaraldehyde in 0.1 M 
cacodylate buffer, pH 7.4 at +4 ·c, and postfixation with osmium 
tetroxide. After dehydration in a series of ethanols, the specimens were 
embedded in Epon and cut in to 70-nm sections, which were stained 
with aqueous uranyl acetate and lead citrate, and studied in a J eol 
JEM-lOOC transmission electron microscope. LC were ident ified by 
t heir general morphology and their specific in t racytoplasmic granules 
(B irbeck gra nules) 117]. 
Statistica l Analysis 
For statistical analys is Student's t-test for paired data was used. 
RESULTS 
Clinical Scores 
At t he sta rt of treatment, t he mean PAST index of t he 
patients was 7.5 ± 5.7 (± SD). During the PUVA course of, on 
the average, 21 irradiations a nd a mea n cumulative UVA d ose 
of 77 J /em~ , t he clinical response of a ll 9 patients was favorable. 
Three patients clea red completely (PAS I = 0), while t he re-
maining 6 patients had minima l residual plaques (PASI = 0.2-
1.2) . The mea n PAS! score at the end of t he t reatment period 
was 0.8 ± 0.8 (± SD) ( p < 0.0.5). During t he follow -up period 
of up to 7 weeks a ll patie nts tayed in remiss ion. 
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L ight Microscopic Findings 
ln samples ta ken from uninvolved skin after 5 treatments 
(and an average cumulative UVA dose of 9.5 J/cm~ ) . the AT-
Pase- positive LC coun t had dropped from the pretreatment 
value of 787 ± 70 cells/mm2 (mean ± SD) to 195 ± 138 cells/ 
mm~ (p < 0.001). After 10- 15 treatments (average cumulative 
UVA dose of 36 J /cm~ ) t he LC number was 122 ± 85 (p < 
0.001) , and it reached a nadir of 60 ± 48 cells/mm2 (p < 0.001) 
in the samples taken after about 20 t reatments and mean 
cumulative UVA dose of 77 J /cm2 • Two weeks after cessation 
of t he PUV A therapy, t he ATPase-positive LC count had 
returned to 291 ± 252 cells/ mm2 (37% of starting value), and 
in t he sample taken 1- 5 weeks later, the LC count was 881 ± 
61 ce ll s/mm~ (112% of starting value). 
Electron Microscopic Findings 
In the pretreatment samples of t he 4 pat ients studied, an 
average of 1<3 Birbeck granule-posit ive cells were identified 
per section (section width 2 mm) . In samples taken after a 
cumulative UVA dose of 7- 9 J /cm2 , no LC were encountered 
in t he sections of 2 of t he patients, while an ave rage of 1.5 cell s 
per section were identified in t he other 2 patients' samples. 
After a cumulative UVA dose of 58- 90 J /cm2 , t he samples of 
a ll 4 patients were negative with regard to LC. In posttreatment 
samples, ta ken 6 weeks after cessation of PUV A, a mean of 1-
3 LC were aga in ident ified in t he samp les of all of the 4 patients. 
The morphology of t he LC granul es was similar in t he pre-
PUVA and post-PUVA samples, but the number of granules 
was decreased in t he post-PUVA specimens. Furthermore, 
whi le t he LC granules were arranged in a parallel fashion in 
t he pre-PU VA specimens, t he granules were more randomly 
located in t he post-PUVA samples (Fig 1). 
Relation Between Clinical Response and LC Findings 
The relation between P ASI scores and ATPase-posit ive LC 
numbers is illustrated in Fig 2. During t he clearing phase, when 
PUV A irradiat ions were given (samp les 1- Ill) , there was a 
striking para llelism between t he regress ion of the psoriasis 
plaques and t he reduction in ATPase-posit ive LC numbers in 
FI G 1. The cytoplasm of a typ ical Langerhans ce ll before t reatment . 
The cytop lasm contains abundant Birbeck granules which are often 
arranged in a para lle l fashion. Bar = 0.5 ;<m. 
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FIG 2. Clinical severity index (PAS!) scores and epide rmal Langer-
hans cell dens ity before (Pre ), during (!- III) , and afte r (IV- V) oral 
photochemotherapy. Mean va lues for 9 psoriatic patients a re given. 
t he biopsied (uninvo lved) skin . While the reduction of LC 
numbers slight ly advanced t he diminution of t he PAS! scores 
both ended up as one-tenth of t heir sta rting value at the end 
of t he PUV A course of, on the average, 21 sessions (sample 
III) . After cessation of t he PUVA therapy (samples IV and V) , 
however, the PASl scores remained low even t hough t he LC 
counts returned to normal , a nd eve n exceeded the start ing 
value by 12% (F ig 2). 
DISCUSSION 
Our present data agree with findin gs from earlier studies 
dealing wi th patients subj ected to either oral [9,12] or topical 
[8,11 ] PUVA therapy. The density of epidermal ATPase-posi-
t ive LC decl ines quite markedly during t he first 1- 2 weeks of 
PUV A therapy. Only in the recent pre liminary repor t of Fried-
mann et al [12], however, was t he fa te of t he LC number after 
term ination of the PUV A course studied. They found no cha nge 
in LC counts 1 week after cessation of t he t herapy, a return to 
half t he pretreatment values by 2 weeks, and full restorat ion of 
t he LC count by 3 weeks. This is consistent with our fi nding 
of 37% of pretreatmen t values at 2 weeks posttherapy, and full 
resto ration, and eve n exceeding the pretreatment value by 12% 
as a rebound effect, at 3-7 weeks. Interestingly, t he reconsti-
tution of ATPase-positive LC after a course of, on the average, 
21 exposures seemed to be as rapid as t hat after a single PUV A 
irradiation [13]. ln a previous study of ours, the mean LC count 
was 42% of t he starting value at day 15 after a single, mildly 
erythemogenic dose of PUVA [13]. 
There have been some indications that destructive effects of 
UV irradiation on LC membrane structures, as ident ified by 
abrogation of t he ATPase enzyme activity, could take place 
without a simila r effect on the number of viable LC, as identi-
fi ed by EM morphology. Aberer et a l [18], using pla in UV 
irradiation from unfiltered UV A sources with an em ission 
spectrum very similar to t hat of the fluorescent tubes of t he 
treatment chamber used in the present study, found only 20-
30% reduction in EM-identified LC at doses (1 - 4 x 40 J /cm2) 
giving up to 85% reduct ion in ATPase-posit ive, light micro-
scopically identified LC. The combination of psora len medica-
t ion and UV A irradiation , however, seems to efficiently deplete 
human ep idermis from EM-identifiable LC. With our screening 
system, no epidermal LC were ident ified in 2 of 4 pat ients after 
a cumulative dose of 7-9 J /cm2 of UVA, and in none of 4 
patients afte r 58-90 J /cm1 . These data are corroborated by the 
statement of Friedm ann et a l [1 2] t hat in their prelimina ry EM 
studies LC had disappea red during the clinical PUV A course 
of psoriasis patients. Ree [10] used morphometric methods at 
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t h e E M level, and reported a reduction in the LC volume 
d e n s ity of 5- 50% in 5 psoriasis patients after 2.5-3 months of 
t h e r apy. The dec rease in LC number, however, probably ex-
ceed ed t hese figures, as t he LC remaining in epidermis during 
pUV A t reatment are known to be 2- 4 t imes larger than nor-
m a lly [8, 14 ). 
I n contrast to previous studies concerning the effect of PUVA 
t r eatment on epidermal LC density [8-12], our study is t he 
o nl y one in which t he LC effects have been correlated to t he 
t h e r apeut ic act ion of t he t reatment by parallel recording of 
seve ri ty of the dermatosis. The very congruent diminution of 
t h e epidermal LC density and t he severi ty of t he dermatosis 
could be interpreted as favoring the hypothesis that effects on 
L C a re instrumental in t he t herapeutic process of photochem-
oth e rapy. However, t hough the functional impairment of t he 
cell s reconstitut ing t he LC population after PUVA therapy 
cannot be excluded, it is reasonable to conclude that the LC 
effect is not t he only relevant factor in t he therapeutic success 
of p soriasis photochemotherapy. Although t he number and 
a rra n gement of LC granules in post-PUVA LC showed some 
d e via ti on from the control state, t he granules were morpholog-
ica lly unimpaired, and we would be very hesitant to draw any 
con c lusions about t he fun ctional capacity of t he cells on the 
bas is of t he EM observations. 
One important limi tation of t he present study, as well as of 
a ll earlier studies on LC during P UV A therapy, lies in t he fact 
t h at t he LC count ings have been made on clinically uninvolved 
skin. This protocol was chosen since preliminary experiments 
b a d s hown t hat LC numbering in psoriatic plaques was subject 
to technica l difficul t ies. While t here is no strict reason to 
beli e ve that t he effect of P UV A on t he LC density would diffe r 
in in volved and uninvolved skin , t he fi nal proof fo r t his must 
a w a i t fur ther studies. In part icular, if observations of more 
subt le changes in LC structures, e.g., in membrane ant igen 
d istribu tion, are to be made, samples of involved skin should 
be included in t he study protocol, since membrane markers of 
L C fro m pso ria tic epidermis are known to differ from those of 
n o rmal LC [7,19 ]. Such studies could shed more li ght on the 
fu nc t ional state of t he LC in the immediate post-P UV A period. 
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